Concurrent paclitaxel, carboplatin and radiotherapy (CMT) with subcutaneous amifostine in advanced squamous cell head and neck cancer (SCCHN): Preliminary results of a phase II study
2004 ◽
Vol 22
(14_suppl)
◽
pp. 5564-5564
Keyword(s):
Phase Ii
◽